摘要
目的探讨2017-2018年高血压药物用药结构。方法采用回顾性分析法对徐闻县人民医院2017-2018年高血压药物用药结构数据进行统计,包括各种高血压药物的药品费用、药品费用占比、费用排名、限定日费用(DDC)、用药频度(DDDs)、DDDs排名及排名比。结果高血压药2017-2018年药品费用排名第一的为钙离子通道阻滞剂(CCB),DDDs最高的是硝苯地平控释片,硝苯地平控释片、非洛地平缓释片、厄贝沙坦3种药物2017-2018年的排名比均为1.0,所有药物DDC均在20元内。结论2017-2018年抗高血压用药结构相对稳定,各种高血压药物在DDC等方面更易被患者所接受。
Objective To explore the drug use structure of hypertension drugs in 2017-2018.Methods Retrospective analysis method was used to make statistics on the data of drug use structure of hypertensives in 2017-2018 in Xuwen County People’s Hospital,including drug cost,drug cost proportion,cost ranking,DDC,DDDs,DDDs ranking and ranking ratio of various hypertensives.Results Calcium channel blocker(CCB)was the most expensive hypertensives drug in 2017-2018,and nifedipine controlled-release tablets were the highest DDDs,and the ranking ratio of nifedipine controlled-release tablets,felodipine sustained-release tablets and irbesartan in 2017-2018 was 1.0,and DDC of all drugs was within 20 yuan.Conclusion From 2017 to 2018,the structure of antihypertensive drugs was relatively stable,and various hypertensive drugs were more easily accepted by patients in DDC and other aspects.
作者
陈文君
CHEN Wen-Jun(Department of Pharmacy,Xuwen County People's Hospital,Zhanjiang 524100,China)
出处
《中国药物经济学》
2020年第5期108-111,共4页
China Journal of Pharmaceutical Economics
关键词
高血压药物
用药结构
日均费用
药品费用
Hypertension drugs
Medication structure
Daily average cost
Drug cost
